| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/01/2004 | EP1450862A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
| 09/01/2004 | EP1450856A2 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 09/01/2004 | EP1450854A2 Vaccine |
| 09/01/2004 | EP1450850A1 Method of administering a thymosin alpha 1 peptide |
| 09/01/2004 | EP1450848A2 Methods of treating liver fibrosis and hepatitis c virus infection |
| 09/01/2004 | EP1450838A1 Method of treating hepatitis virus infection with a multiphasic interferon delivery profile |
| 09/01/2004 | EP1450836A2 Method for short-term and long-term drug dosimetry |
| 09/01/2004 | EP1450833A2 Anti-hsv agent for inhibiting replication of hsv-1 and hsv-2 and method of producing a substance having anti-hsv activity |
| 09/01/2004 | EP1450825A1 Use of selenite-containing compounds to be topically or buccally administered |
| 09/01/2004 | EP1450823A2 Biocidal mixture of 2-propenal-releasing polymer and isothiazolones |
| 09/01/2004 | EP1450821A1 Immunostimulatory oligodeoxynucleotides |
| 09/01/2004 | EP1450809A2 Nucleosides preparation thereof and use as inhibitors of rna viral polymerases |
| 09/01/2004 | EP1450803A1 New uses for anti-malarial therapeutic agents |
| 09/01/2004 | EP1450778A2 Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases |
| 09/01/2004 | EP1450775A2 Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections |
| 09/01/2004 | EP1450769A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 09/01/2004 | EP1450767A1 Micropherules containing a pleuromutilin derivative |
| 09/01/2004 | EP1450762A1 Novel formulation |
| 09/01/2004 | EP1450753A1 Antimicrobial composition comprising soy oil, rice bran oil and jojoba oil |
| 09/01/2004 | EP1450752A2 Multivalent streptococcal vaccine compositions and methods for use |
| 09/01/2004 | EP1450750A2 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 09/01/2004 | EP1450626A1 A novel non-antibiotic strategy against ogip infections based on an activated cereal product or ferric quinate |
| 09/01/2004 | EP1242410B1 Novel compounds |
| 09/01/2004 | EP1237889B1 Antibiotic sultam and sultone derived oxazolidinones |
| 09/01/2004 | EP1228024B1 Novel hydronaphthalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 09/01/2004 | EP1140851B1 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 09/01/2004 | EP1131037B1 Process for the manufacture of liquid filled capsules |
| 09/01/2004 | EP1127058B1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 09/01/2004 | EP1047769B1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd |
| 09/01/2004 | EP1042482B1 Acetyl-coa-carboxylase from candida albicans |
| 09/01/2004 | EP1037529A4 Composition useful for providing one-step surgical preparation and drape |
| 09/01/2004 | EP0984955B1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing tnf alpha levels |
| 09/01/2004 | EP0974347B1 Antiviral agents |
| 09/01/2004 | EP0954296B9 Use of bronopol for the treatment of diseases in fish |
| 09/01/2004 | EP0923530B1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 09/01/2004 | CN1526020A Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins. |
| 09/01/2004 | CN1526018A Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/01/2004 | CN1525979A Bridged bicyclic serine protease inhibitors |
| 09/01/2004 | CN1525978A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/01/2004 | CN1525962A De Rock Herman Augustinus |
| 09/01/2004 | CN1525957A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 09/01/2004 | CN1525956A Alpha -amino-n-hydroxy-acetamide derivatives |
| 09/01/2004 | CN1525955A Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/01/2004 | CN1525954A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 09/01/2004 | CN1525869A Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
| 09/01/2004 | CN1525866A Treatment using neublastin polypeptides |
| 09/01/2004 | CN1525865A Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 09/01/2004 | CN1525863A Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 09/01/2004 | CN1525862A Novel receptors for dollar i(helicobacter pylori) and use thereof |
| 09/01/2004 | CN1525857A Method for regulation of gene expression in eukaryotic cells using nordihydroguaiaretic acid derivatives |
| 09/01/2004 | CN1525852A Granules and granules coated with a masked taste |
| 09/01/2004 | CN1524960A Efficient synthetic routes for the preparation of rhinovirus protease inhibitors and key intermediates |
| 09/01/2004 | CN1524877A Construction and preparation of stroma cell derivative factor - 1ª‡ recombinant mutant |
| 09/01/2004 | CN1524868A A-type crystal of Clarithromycin |
| 09/01/2004 | CN1524865A Crystalline forms of adefovir dipivoxil ester |
| 09/01/2004 | CN1524860A Cefetamet natrium, its preparing process and its application as antibacterial agent for injection |
| 09/01/2004 | CN1524854A Thiazolidine diketone derivatives, preparing process and application of pharmaceutical preparations of the same |
| 09/01/2004 | CN1524583A Use of gene for expressing Notch-ligand in production of medicinal preparations for immunotherapy |
| 09/01/2004 | CN1524576A Composite thymus peptide with immunoregulation function |
| 09/01/2004 | CN1524575A Virulence genes and proteins, and their use |
| 09/01/2004 | CN1524574A Oral medicament of viral infection preventing agent |
| 09/01/2004 | CN1524571A A medicament and its preparation process |
| 09/01/2004 | CN1524568A Preparation method of phthisis treating capsule |
| 09/01/2004 | CN1524564A Capsule for curing enteritis and bloody flux |
| 09/01/2004 | CN1524558A Immunologic function booster for treating AIDS and SARS |
| 09/01/2004 | CN1524556A San Er antibacterial injection medicine |
| 09/01/2004 | CN1524553A Exterior-applied medicine for treating dermatopathy |
| 09/01/2004 | CN1524551A Use of Chinese herbal medicine Lsodon amethystoides and Isodon longitubus in medicine |
| 09/01/2004 | CN1524548A Liquid traditional Chinese medicine for treating skin disease and its preparation process |
| 09/01/2004 | CN1524546A Composition containing radix notoginseng, eucommia and american ginseng |
| 09/01/2004 | CN1524531A Compound terbinafine hydrochloride composition of skin antibacterial drugs |
| 09/01/2004 | CN1524530A Method for preparing ganciclovir intravenous fluid |
| 09/01/2004 | CN1524527A Piperidine derivatives useful as CCR5 antagonists |
| 09/01/2004 | CN1164575C Tetrahydroisoquinoline derivative with antifungal activity and its preparation method |
| 09/01/2004 | CN1164332C Preparation method of horse SARS-resisting serum |
| 09/01/2004 | CN1164330C Genetically engineered rabies virus vaccine with recombination-defective adenovirus carrier |
| 09/01/2004 | CN1164314C Achillea total flavone capsule |
| 09/01/2004 | CN1164313C Chinese medicine for treating women's menalgia, pelvic infection and vaginitis |
| 09/01/2004 | CN1164298C Chinese medicine for treating cold and cough and its preparation method |
| 09/01/2004 | CN1164283C Pneumonia treating Chinese medicine powder |
| 09/01/2004 | CN1164267C Medical use of Chlorogenic acid and formulation thereof |
| 09/01/2004 | CN1164256C Medicine powder for eliminating foot smell and bromhidrosis and its prepn process |
| 08/31/2004 | US6784291 Splice-region antisense composition and method |
| 08/31/2004 | US6784283 Peptide antibiotics |
| 08/31/2004 | US6784210 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
| 08/31/2004 | US6784198 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/31/2004 | US6784195 Extracellular signal regulated kinase (erk); anticancer agents and protein kinase inhibitors |
| 08/31/2004 | US6784193 Mutilin derivatives and their use as antibacterials |
| 08/31/2004 | US6784188 Urea substituted imidazoquinolines |
| 08/31/2004 | US6784174 Inhibitors of the production of cytokines such as tnf |
| 08/31/2004 | US6784169 Metalloprotease inhibitor; antiinflamamtory agents; rheumatic disorders; cardiovascular disorders; controlling cell proliferation |
| 08/31/2004 | US6784166 For the treatment of diseases mediated by the hepatitis c virus |
| 08/31/2004 | US6784164 Choline binding proteins for anti-pneumococcal vaccines |
| 08/31/2004 | US6784161 Method for the treatment or prevention of flavivirus infections using nucleoside analogues |
| 08/31/2004 | US6783981 Capable of delivering anti-viral inhibitory rna molecules to target cells; gene therapy |
| 08/31/2004 | US6783977 Internal ribosome entry site and vector containing same |
| 08/31/2004 | US6783960 Polypeptide for use in the treatment of thrombosis and sepsis |
| 08/31/2004 | US6783935 Genetic polymorphism of MxA protein and use thereof |
| 08/31/2004 | US6783763 Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines |
| 08/31/2004 | US6783753 Rapidly produces peak plasma concentrations of the compound. |